Farallon Capital

#### I. Institutional Overview Farallon Capital Management, L.L.C., founded in 1986 by Thomas Steyer, has long stood as a titan in the multi-strategy hedge fund landscape. As we dissect the 13F filing for the fourth quarter of 2025, we observe an institution that manages a reported portfolio value of approximately **$17.32 billion**, spread across **140 distinct holdings**. This scale places Farallon in the upper echelon of global investment managers, possessing the "smart money" gravity required to influence market sentiment and liquidity. The institutional "psychological portrait" of Farallon this quarter reveals a sophisticated blend of opportunistic aggression and disciplined risk management. With a portfolio value exceeding $17 billion and 140 stocks, Farallon maintains a **diversified yet concentrated** structure. While the number of holdings suggests a wide-reaching research net, a closer look at the concentration—where the top 10 holdings represent a significant portion of the total AUM—indicates a "high-conviction" investment philosophy. Farallon does not merely "index" the market; it makes profound bets on specific companies and sectors where it perceives a distinct informational or analytical advantage. The scale trend for Farallon in Q4 2025 appears robust. The reported value of $17.32 billion reflects a firm that is actively deploying capital in a complex macroeconomic environment. The institutional style, though not explicitly labeled in the metadata, is clearly identifiable through its actions: it is a **fundamental-driven, multi-strategy powerhouse** with a heavy leaning toward **Event-Driven** and **Value-with-Growth** characteristics. The firm’s ability to navigate through 140 positions while maintaining massive "ballast" positions in sectors like Healthcare and Technology suggests a highly evolved institutional infrastructure capable of deep-dive fundamental research across disparate industries. Farallon’s current state can be summarized as **"Strategic Consolidation with a Growth Tilt."** The institution is not retreating; rather, it is refining its front lines. By maintaining a high number of stocks, it ensures it has "eyes" on various market niches, but by concentrating its billions into top-tier names like Revolution Medicines (RVMD), Microsoft (MSFT), and Amazon (AMZN), it signals where its true confidence lies. This quarter's report is a testament to Farallon's role as a sophisticated arbiter of value, moving away from legacy software and industrial plays toward the next frontier of AI infrastructure and specialized biotechnology. The psychological state of the firm appears to be one of **calculated optimism**. There is no evidence of panic selling or broad-based de-risking. Instead, the "slimming" of certain positions and the total exit from others (like Autodesk and Intuit) suggests a rigorous "survival of the fittest" mandate within the portfolio. Farallon is recycling capital from mature or slowing growth stories into high-velocity opportunities in cybersecurity, semiconductors, and alternative financials. This is the hallmark of an institution that is not just reacting to the market, but attempting to stay two steps ahead of the macro cycle. #### II. Sector Allocation Analysis The sector allocation of Farallon Capital in Q4 2025 provides a masterclass in thematic investing and macro-positioning. The distribution of assets across different industries reveals a firm that is heavily overweight in specific "innovation frontiers" while remaining tactical in cyclical and defensive areas. | Sector | Weight (%) | Trend/Judgment | | :--- | :--- | :--- | | **Healthcare** | **50.01** | **Dominant Core / High Conviction** | | **Technology** | **17.24** | **Growth Engine / AI Infrastructure** | | **Financials** | **13.26** | **Strategic Allocation / Alternative Assets** | | **Consumer Discretionary** | **6.12** | **Selective Growth** | | **Communication Services** | **6.02** | **Platform Plays** | | **Industrials** | **5.14** | **Tactical / Specialized Engineering** | | **Real Estate** | **1.31** | **Niche Exposure** | | **Consumer Staples** | **0.71** | **Minimalist Defensive** | | **Others** | **0.18** | **Residual / Tail** | | **Energy** | **0.01** | **Negligible** | **2.1 Concentration and Macro Strategy** The most striking feature of Farallon’s sector layout is the **extreme concentration in Healthcare**, which accounts for a staggering **50.01%** of the portfolio. When combined with Technology (17.24%) and Financials (13.26%), the top three sectors represent **80.51%** of the total reported value. This level of concentration is indicative of a "Specialist" approach within a "Generalist" framework. Farallon is essentially operating as a massive Biotech/Healthcare fund with a significant Tech/Finance overlay. The 50% allocation to Healthcare suggests that Farallon views this sector not just as a defensive hedge, but as the primary theater for generating alpha. This likely stems from a belief in the "Golden Age of Biotechnology," where breakthroughs in oncology (as seen in their RVMD and NTRA holdings), gene editing, and medical devices are creating idiosyncratic value regardless of the broader macro-economic headwinds. **2.2 Sector Rotation and Industry Insights** In the Technology sector (17.24%), we see a clear rotation signal. Farallon is moving away from "Legacy SaaS" and "General Enterprise Software" (exiting ADSK and INTU) and moving aggressively into **AI Infrastructure and Cybersecurity** (adding MSFT, AMZN, and new positions in CYBR, SNPS, and AVGO). This suggests a macro judgment that the "Software-as-a-Service" boom has reached a maturity phase, and the next leg of growth belongs to the companies providing the "picks and shovels" for the AI revolution. The Financials allocation (13.26%) is equally telling. The addition of **KKR & Co. Inc.** and the continued holding of **Aon plc** and **The Charles Schwab Corporation** indicate a preference for "Capital Market Enablers" and "Alternative Asset Managers." Farallon seems to be betting that in a complex interest rate environment, firms that manage private capital or provide essential financial risk management (Aon) will outperform traditional retail banks. **2.3 Macroeconomic Judgment** Based on this allocation, Farallon’s judgment on the macroeconomic cycle appears to be **"Growth-Oriented Resilience."** By shunning Consumer Staples (0.71%) and Energy (0.01%), they are signaling a lack of interest in traditional defensive or commodity-linked plays. Instead, they are finding "defensiveness" through the **non-cyclical nature of Healthcare innovation** and "offense" through **Big Tech dominance**. The shift toward Communication Services (6.02%) and Consumer Discretionary (6.12%)—represented by names like Amazon and Disney—suggests they believe the consumer remains healthy enough to support platform-based giants, but they are being highly selective. They are not buying the "broad consumer"; they are buying the "dominant ecosystem." The minimal exposure to Industrials (5.14%) and Real Estate (1.31%) further reinforces the idea that Farallon is avoiding sectors that are highly sensitive to interest rate fluctuations or physical economic cycles. They are prioritizing **intellectual property, data, and biological breakthroughs** over physical assets and traditional manufacturing. #### III. Top 10 Holdings Deep Dive The Top 10 holdings of Farallon Capital represent the "ballast stones" of the portfolio, accounting for a massive portion of the firm's risk and potential reward. **Table 3.1: Top 10 Holdings Detail** | Rank | Ticker | Company | Market Value | W ---